Acasti Pharma Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 61.47 | -100% | -0.1885 | -100% |
| P/S |
|
26141.39 | 33.58 | 77747.02% |
|
|
| P/BV |
|
0.5263 | 4.79 | -89.02% |
|
|
| P/FCF |
|
0 | 60.06 | -100% |
|
|
| Ev/Ebitda |
|
-0.8397 | -17.26 | -95.14% |
|
|
| Ev/S |
|
948.93 | 22.49 | 4120.02% |
|
|
| Ev/FCF |
|
-0.7681 | 67.63 | -101.14% |
|
|
| E/P |
|
0 | 0.0168 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-113010 | -12.31 | 918306.36% | -58900.57 | +91.87% |
| ROE |
|
-22.95 | 9.39 | -344.35% |
|
|
| ROA |
|
-19.5 | 0.1519 | -12933.9% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-128530 | -25.64 | 501173.98% |
|
|
| ROCE |
|
-18.32 | 14.76 | -224.14% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0318 | -3.68 | -99.14% | -0.0113 | +181.98% |
| Nеt Debt/Ebitda |
|
2.04 | -4.07 | -150.06% |
|
|
| Debt/Ratio |
|
0.0049 | 0.199 | -97.54% |
|
|
| Debt/Equity |
|
1.42 | 1.67 | -14.48% |
|
|
| Debt/Net Income |
|
-0.0279 | 10.34 | -100.27% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5399 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2331 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4916 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.32 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5399 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-97.69 | 76.2 | -228.2% | ||
| Growth impulse Ebitda in 5 years |
|
-27.09 | 44.75 | -160.54% | ||
| Growth impulse Net Income in 5 years |
|
-29.77 | -15.36 | 93.82% | ||
| Growth impulse FCF in 5 years |
|
-25.12 | -9.39 | 167.52% | ||
| Growth impulse EPS in 5 years |
|
-87.03 | -84.03 | 3.57% |
IP Score
2.56/10
